• Skip to main content
  • Skip to footer

Life Sciences British Columbia

  • Members Area |
  • Contact Us
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
    • LSBC Hall of Fame
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2023 Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
    • BC Labour Market Study
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Programs
    • Volunteering
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login

Aequus Pharmaceuticals

Member Profile

Aeequs Pharmaceuticals is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus’ sales and marketing efforts are based in Canada, targeting highly specialized therapeutic areas including ophthalmology and transplant.

We continue to build pipeline in ophthalmology and we have recently added a number of commercial stage products through in-licensing agreements. Our commercial infrastructure with specialty sales representatives is currently promoting two specialty medicines to physicians and two over the counter (“OTC”) products to eye care professionals.

Our commercial programs are supported and validated by insights from patients, physicians, and payers to ensure there is a realizable benefit for them from our work in advancing these products. Aequus’ management team has a proven track record of successfully managing the required clinical development, regulatory approval processes, and marketing of products either directly or through collaborations. We continue to leverage our internal capabilities and know-how to execute an efficient commercial strategy and development plan to drive shareholder value.

Sector
Biotechnology, Therapeutics
Area of Expertise
  • Neurological Diseases
  • Ophthalmology
Company Stage Commercial Stage, Public Company
Stock Ticker AQS - TSX
Stock Ticker AQSZF - OTCQB

Member Profile

Biotechnology, Therapeutics

Aequus Pharmaceuticals

AEQUUS-PHARMA logo
  • Website www.aequuspharma.ca
  • Phone +1 (604) 336 7906
  • Email info@aequuspharma.ca
  • Address
    2820 - 200 Granville Street
    Vancouver, BC
    V6C 1S4
  • Leadership Contact
    Doug Janzen, Chairman & CEO
    Follow us:
  • Twitter
  • Facebook
  • LinkedIn
  • Instagram
  • News
  • Jobs

January 24, 2022

Aequus Extends Commercial Agreement for Specialty Product Tacrolimus IR in Canada

January 11, 2022

Sandoz and Aequus Agree to 1-Year Extension on Vistitan in Canada

August 17, 2021

Aequus and reVision to Collaborate on Stargardt Disease Program

No current content.

  • Twitter
  • Linkedin
Tweets by Aequus Pharmaceuticals
Connect with us LinkedIn

© 2023 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us